
Theranostics
Recurrent Prostate Cancer
Journal: Appl Radiol, volume: Jul/Aug, pages 40-43
Year: 2021
Theranostics
Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks
Journal: Clinical Oncology
Year: 2021
Theranostics
Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments
Journal: Eur Urol Oncol, volume: Mar;2(2), pages 152-162
Year: 2019
Theranostics
Treatment outcome, toxicity, and predictive factors for radioligand therapy with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer
Year: 2018
Theranostics
[177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
Journal: The Lancet Oncology, volume: Jun; 19(6), pages 825-833
Year: 2018
Theranostics
Current status of theranostics in prostate cancer
Journal: Current status of theranostics in prostate cancer
Year: 2017